Recent Transactions

New Haven Group represents Landlord in 18,000 sf lease to Durata Therapeutics

September 2012 -- Durata Therapeutics, a public bio pharmaceutical company, recently signed a lease for approximately 18,000 square feet at 322 East Main Street in Branford, CT.  Durata Therapeutics is a bio pharmaceutical company that went public this summer.  The Branford building will house the company's research and development headquarters bringing a significant amount of quality jobs to the region, formerly based in New Jersey.  Steven Inglese, principal of the New Haven Group represented the owner in the lease negotiations.  

The State of Connecticut also recently inked a deal for the company to grow in Connecticut by providing a $2,250,000 grant to the company who will create as many as 80 new jobs in the State.   Read more about the state deal in the New Haven Register.

322 East Main Street is a three story class A office building, just off exit 55 on Interstate 95.  The building is suitable for professional office, medical and research and is exclusively represented for lease by the New Haven Group.